藍思科技(300433.SZ):子公司擬99億元收購可勝泰州和可利泰州各100%股權
格隆匯 8 月 18日丨藍思科技(300433.SZ)公告,公司及全資子公司藍思國際(香港)有限公司(以下簡稱“藍思國際”或“買方”)與LyraInternationalCo.,Ltd.(以下簡稱“賣方”)、可成科技股份有限公司(以下簡稱“可成科技”)於2020年8月18日簽署了《股權買賣契約》(以下簡稱“股權買賣契約”),藍思國際以現金99億元人民幣收購賣方持有的可勝科技(泰州)有限公司(以下簡稱“可勝泰州”)以及可利科技(泰州)有限公司(以下簡稱“可利泰州”,與可勝泰州合稱“目標公司”)各100%的股權(以下簡稱“本次交易”)。公司為藍思國際履約提供擔保,可成科技為賣方履約提供擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.